EGFR, which is overexpressed in approximately 30% of human primary tumors, is correlated with nodal status, tumor size, histological grade, Ki-67 index, ER/PR status, and prognosis in breast cancer, and has been a target of anti-cancer drugs22,46–52. Here, EGFR is linked to breast carcinoma.